Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-17

Clinical Trial Update: Locally Delivered 1% Metformin Gel in Peri-implantitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating locally delivered 1% metformin gel for peri-implantitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Gel 1% (locally delivered) (metformin)

Snippet

Sponsor: King Saud University | Conditions: Peri-Implantitis | Phase 4 | Status: COMPLETED